4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001493152-24-012070
Options or other derivatives
- Director acquired 22,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrage Khalil Director | 2024-03-25 | Grant or award · PTIX Common stock Options | +22,500 | $1.74 | $39,150 | 22,500 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…